The NIBIB provides support for Investigator-Initiated NIH Small Research Grant applications from highly qualified applicants who are poised to pursue research in interdisciplinary research at the interface between the biomedical and the mathematical, physical, or engineering sciences. The NIBIB is interested in applications where the science is is focused on the discovery, development, and clinical translation of new existing technologies. The NIBIB is also interested in technological studies that enable fundamental biomedical discoveries across a broad spectrum of biological processes, disorders, and diseases and have significant potential for direct medical application. The specific aims of an application for NIBIB funding, therefore, should involve a preponderance of technological effort. In most instances, technology development will occur in a vacuum, but will have a target medical application. However, in some instances, a technology-based application is so closely aligned to a specific disease or organ system that assignment to another NIH Institute will better serve the applicant. Applicants are invited to look at the NIBIB Scientific Program Areas: https://www.nibib.nih.gov/research/scientific-program-areas.
Applicants seeking NIBIB funding opportunities are strongly encouraged to contact the NIBIB staff listed below and to provide a brief description of the specific aims of the proposed project. Although such a description is not required, is not binding, and does not enter into the review of a subsequent application, the information will allow NIBIB staff to evaluate the program relevance of the proposed research and to provide feedback to the applicant. This feedback is intended to help the applicant in the decision to submit an application to the NIBIB.
For more information contact:
Tatjana Atanasijevic, Ph.D.
Division of Applied Science and Technology
National Institute of Biomedical Imaging and Bioengineering
Email: Tatjana.Atanasijevic@nih.gov
Access the NOFO here: PA-20-200: NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)